Micronucleus induction by metronidazole in rat vaginal mucosa

Environmental and Molecular Mutagenesis

Volumn 47, Issue 5, 2006, Pages 352-356

  Ornelas Aguirre, José Manuel ^a   Gómez Meda, Belinda C ^b   Zamora Perez, Ana L ^b   Ramos Ibarra, Maria L ^b,c   Batista González, Cecilia M ^b,c   Zúñiga González, Guillermo M ^b  

^a UNIVERSIDAD AUTÓNOMA DE GUADALAJARA   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c UNIVERSITY OF GUADALAJARA   (Mexico)

Author keywords

Micronuclei; Proestrus; Vaginal cells

Indexed keywords

FLUOROURACIL; METRONIDAZOLE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHEMICAL MUTAGENESIS; CONTROLLED STUDY; FEMALE; GENOTOXICITY; MICRONUCLEUS; NONHUMAN; PROESTRUS; RAT; UTERINE CERVIX; UTERINE CERVIX CYTOLOGY; VAGINA; VAGINA MUCOSA;

ADMINISTRATION, INTRAVAGINAL; ANIMALS; ANTI-INFECTIVE AGENTS; FEMALE; METRONIDAZOLE; MICRONUCLEI, CHROMOSOME-DEFECTIVE; MICRONUCLEUS TESTS; MUCOUS MEMBRANE; MUTAGENS; PROESTRUS; RATS; RATS, WISTAR; VAGINA;

RODENTIA;

EID: 33745164284     PISSN: 08936692     EISSN: 10982280     Source Type: Journal    
DOI: 10.1002/em.20214     Document Type: Article

References (43)

1. A-Kareem AM, Fleiszer DM, Rochards GK, Senterman MK, Brown RA. 1984. Effect of long-term metronidazole (MTZ) therapy on experimental colon cancer in rats. J Surg Res 36:547-552.
2. Bendesky A, Menendez D, Ostrosky-Wegman P. 2002. Is metronidazole carcinogenic? Mutat Res 511:133-144.
3. Dalrymple JL, Russell AH, Lee SW, Scudder SA, Leiserowitz GS, Kinney WK, Smith LH. 2004. Chemoradiation for primary invasive squamous carcinoma of the vagina. Int J Gynecol Cancer 14:110-117.
4. Diav-Citrin O, Shechtman S, Gotteiner T, Arnon J, Ornoy A. 2001. Pregnancy outcome after gestational exposure to metronidazole: A prospective controlled cohort study. Teratology 63:186-192.
5. Elizondo G, Gonsebatt ME, Salazar AM, Lares I, Santiago P, Herrera J, Hong E, Ostrosky-Wegman P. 1996. Genotoxic effects of metronidazole. Mutat Res 370:75-80.
6. el-Nahas AF, el-Ashmawy IM. 2004. Reproductive and cytogenetic toxicity of metronidazole in male mice. Basic Clin Pharmacol Toxicol 94:226-231.
7. Fahrig R, Engelke M. 1997. Reinvestigation of in vivo genotoxicity studies in man. I. No induction of DNA strand breaks in peripheral lymphocytes after metronidazole therapy. Mutat Res 395:215-221.
8. Foster R, Blowers SD, Cinelli S, Marquardt H, Westendorf J. 1992. Mutagenicity testing of imidazole and related compounds. Mutat Res 298:71-79.
9. Goldenberg RL, Klebanoff M, Carey JC, Macpherson C. 2001. Metronidazole treatment of women with positive fetal fibronectin test result. Am J Obstet Gynecol 185:485, 486.
10. Guzmán P, Sotelo-Regil RC, Mohar A, Gonsebatt ME. 2003. Positive correlation between the frequency of micronucleated cells and dysplasia in Papanicolaou smears. Environ Mol Mutagen 41:339-343.
11. Hartley-Asp B. 1981. Metronidazole: Absence of mammalian cytogenicity. Scand J Infect Dis 26:72-74.
12. Klebanoff MA, Carey JC, Hauth JC, Hillier SL, Nugent RP, Thom EA, Ernest JM, Heine RP, Wapner RJ, Trout W, Moawad A, Leveno KJ, Miodovnik M, Sibai BM, Van Dorsten JP, Dombrowski MP, O'Sullivan MJ, Varner M, Langer O, McNellis D, Roberts JM, National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. 2001. Failure of metronidazole to prevent preterm delivery among pregnant women with asymptomatic Trichomonas vaginalis infection. N Engl J Med 345:487-493.
13. Koch RL, Beaulie BB, Chrystal EJT, Goldman P. 1981. A metronidazole metabolite in human urine and its risk. Science 211:398-400.
14. LaRusso NF, Tomasz M, Muller M, Lipman R. 1977. Interaction of metronidazole with nucleic acids in vitro. Mol Pharmacol 13:872-882.
15. Leal-Garza CH, Cerda-Flores RM, Leal-Elizondo E, Cortés- Gutiérrez EI. 2002. Micronuclei in cervical smears and peripheral blood lymphocytes from women with and without cervical uterine cancer. Mutat Res 515:57-62.
16. Legator MS, Connor TH, Stoeckel M. 1975. Detection of mutagenic activity of metronidazole and niridazole in body fluids of humans and mice. Science 188:1118, 1119.
17. Lopez-Nigro MM, Palermo AM, Mudry MD, Carballo MA. 2003. Cytgenetic evaluation of two nitroimidazole derivatives. Toxicol In Vitro 17:35-40.
18. Maiman M, Watts DH, Andersen J, Clax P, Merino M, Kendall MA. 1999. Vaginal 5-fluorouracil for high-grade cervical dysplasia in human immunodeficiency virus infection: A randomized trial. Obstet Gynecol 94:954-961.
19. Maneo A, Landoni F, Cormio G, Colombo A, Placa F, Pellegrino A, Mangioni C. 1999. Concurrent carboplatin/5-fluorouracil and radiotherapy for recurrent cervical carcinoma. Ann Oncol 10:803-807.
20. McVan BF. 1993. Physician's Drug Handbook. Springhouse, PA: Springhouse Corporation. pp 1030-1033.
21. Morgan I. 1978. Metronidazole treatment in pregnancy. Int J Gynecol Obstet 15:501, 502.
22. Mudry MD, Carballo M, Labal de Vinuesa M, Gonzalez Cid M, Larripa I. 1994. Mutagenic bioassay of certain pharmacological drugs. III. Metronidazole (MTZ). Mutat Res 305:127-132.
23. Murta EF, Neves Junior MA, Sempionato LR, Costa MC, Maluf PJ. 2005. Vaginal intraepithelial neoplasia: Clinical-therapeutic analysis of 33 cases. Arch Gynecol Obstet 272:261-264.
24. Nagae Y, Miyamoto H, Suzuki Y, Shimizu H. 1991. Effect of induction of micronuclei by mutagens in male mice. Mutat Res 263:21-26.
25. Nakamura M, Fort FL, Kikuchi Y. 1993. Fetal liver micronucleus assay in mice of 5-fluorouracil and related compounds. Mutat Res 291:29-34.
26. Neal SB, Probst GS. 1984. Assessment of sister chromatid exchange in spermatogonia and intestinal epithelium in Chinese hamsters. Basic Life Sci 29:613-628.
27. Ohuchida A, Furukawa A, Yoshida J, Watanabe M, Aruga F, Miwa Y, Shinkawa K, Kinae N. 1992. Micronucleus assays on 5-fluorouracil and 6-mercaptopurine with mouse peripheral blood reticulocytes. Mutat Res 278:139-143.
28. Ostrosky-Wegman P, Asseff IL, Santiago P, Elizondo G, Montero R. 1994. Metronidazole hprt mutation induction in sheep and the relationship with its elimination rate. Mutat Res 307:253-259.
29. Piper JM, Mitchel EF, Ray WA. 1993. Prenatal use of metronidazole and birth defects: No association. Obstet Gynecol 82:348-352.
30. Reitz M, Rumpf M, Knitza R. 1991. DNA single strand-breaks in lymphocytes after metronidazole therapy. Arzneimittelforschung 41:155, 156.
31. Rodríguez-Ariza A, Abril N, Navas JI, Dorado G, López-Barea J, Pueyo C. 1992. Metal mutagenicity and biochemical studies on bivalve molluscs from Spanish coasts. Environ Mol Mutagen 19:112-124.
32. Rustia M, Shubik P. 1979. Experimental induction of hepatomas, mammary tumors, and other tumors with metronidazole in noninbred sas: MRC(WI)BR rats. J Natl Cancer Inst 63:863-868.
33. Sloan DA, Fleiszer DM, Richards GK, Murray D, Brown RA. 1983. Increased incidence of experimental colon cancer associated with long-term metronidazole therapy. Am J Surg 145:66-70.
34. Solís-Sánchez JA. 2005. Diccionario de Especialidades Farmacéuticas-PLM. México: Thomson. pp 1349, 1350, 1476-1479.
35. Speck WT, Stein AB, Rosenkranz HS. 1976. Mutagenicity of metronidazole: Presence of several active metabolites in human urine. J Natl Cancer Inst 56:283, 284.
36. Stopper H, Kuhnel A, Podschun B. 1994. Combination of the chemotherapeutic agent 5-fluorouracil with an inhibitor of its catabolism results in increased micronucleus induction. Biochem Biophys Res Commun 203:1124-1130.
37. Syed TA, Qureshi ZA, Ahmad SA, Ali SM. 2000. Management of intravaginal warts in women with 5-fluorouracil (1%) in vaginal hydrophilic gel: A placebo-controlled double-blind study. Int J STD AIDS 11:371-374.
38. Torres-Bugarín O, De Anda-Casillas A, Ramírez-Muñoz MP, Sánchez-Corona J, Cantú JM, Zúñiga G. 1998. Determination of diesel genotoxicity in firebreathers by micronuclei and nuclear abnormalities in buccal mucosa. Mutat Res 413:277-281.
39. Urtasun RC, Rabin HR, Partington J. 1983. Human pharmacokinetics and toxicity of high-dose metronidazole administered orally and intravenously. Surgery 93:145-148.
40. Visser AA, Hundt HK. 1984. The pharmacokinetics of a single intravenous dose of metronidazole in pregnant patients. J Antimicrob Chemother 13:279-283.
41. Zúñiga-González G, Gómez-Meda BC, Zamora-Perez A, Ramos-Ibarra ML, Batista-González CM, Espinoza-Jiménez S, Gallegos-Arreola MP, Álvarez-Moya C, Torres-Bugarín O. 2003a. Induction of micronuclei in proestrus vaginal cells from colchicine- and cyclophosphamide-treated rats. Environ Mol Mutagen 42:306-310.
42. Zúñiga-González G, Torres-Bugarín O, Zamora-Perez A, Gómez-Meda BC, Ramos-Ibarra ML, Gallegos-Arreola MP, Flores-García A, López-Uribe A. 2003b. Induction of micronucleated erythrocytes in mouse peripheral blood after cutaneous application of 5-fluorouracil. Arch Med Res 34:141-144.
43. Zúñiga-González GM, Gómez-Meda BC, Zamora-Perez A, Ramos-Ibarra ML, Batista-González CM, Lemus-Varela ML, Rodríguez-Ávila JL, Gallegos-Arreola MP. 2005. Micronucleated erythrocyte frequencies in old and new world primates: Measurement of micronucleated erythrocyte frequencies in peripheral blood of Callithrix jacchus as a model for evaluating genotoxicity in primates. Environ Mol Mutagen 46:253-259.